Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 332.00
+15.00 (4.73%)
Mar 10, 2026, 12:40 PM KST
Aprogen Medicines Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 97,809 | 219,892 | 234,315 | 399,707 | 335,573 | 374,121 | Upgrade
|
| Market Cap Growth | -52.46% | -6.16% | -41.38% | 19.11% | -10.30% | -10.38% | Upgrade
|
| Enterprise Value | 551,385 | 604,604 | 577,535 | 792,820 | 588,371 | 548,883 | Upgrade
|
| Last Close Price | 317.00 | 776.00 | 960.00 | 1716.00 | 5055.00 | 6135.00 | Upgrade
|
| PS Ratio | 0.78 | 1.47 | 1.56 | 5.10 | 12.76 | 2.94 | Upgrade
|
| PB Ratio | 0.20 | 0.50 | 0.56 | 0.87 | -416.12 | 0.54 | Upgrade
|
| P/TBV Ratio | 1.23 | 1.44 | 1.67 | 1.93 | - | 1.19 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 18.75 | Upgrade
|
| P/OCF Ratio | - | - | - | - | - | 16.60 | Upgrade
|
| EV/Sales Ratio | 4.37 | 4.03 | 3.84 | 10.12 | 22.38 | 4.32 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 76.74 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 192.99 | Upgrade
|
| EV/FCF Ratio | -16.16 | - | - | - | - | 27.50 | Upgrade
|
| Debt / Equity Ratio | 0.51 | 0.26 | 0.30 | 0.20 | -560.94 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 11.98 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 4.29 | Upgrade
|
| Net Debt / Equity Ratio | 0.25 | 0.16 | 0.20 | 0.09 | -536.27 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.60 | -1.06 | -1.27 | -0.48 | -6.13 | -21.22 | Upgrade
|
| Net Debt / FCF Ratio | -3.62 | -1.22 | -1.00 | -0.32 | -3.63 | -7.61 | Upgrade
|
| Asset Turnover | 0.18 | 0.25 | 0.25 | 0.14 | 0.04 | 0.17 | Upgrade
|
| Inventory Turnover | 1.35 | 1.88 | 1.90 | 1.85 | 1.55 | 5.37 | Upgrade
|
| Quick Ratio | 0.62 | 0.57 | 0.53 | 0.85 | 0.07 | 3.11 | Upgrade
|
| Current Ratio | 0.99 | 1.19 | 1.15 | 2.35 | 0.24 | 5.11 | Upgrade
|
| Return on Equity (ROE) | -31.66% | -23.40% | -22.14% | -50.45% | -34.60% | -5.41% | Upgrade
|
| Return on Assets (ROA) | -8.84% | -9.37% | -9.94% | -13.57% | -9.13% | 0.24% | Upgrade
|
| Return on Invested Capital (ROIC) | -17.00% | -17.86% | -18.90% | -25.00% | -19.76% | 0.59% | Upgrade
|
| Return on Capital Employed (ROCE) | -18.00% | -18.20% | -20.30% | -22.90% | -172.00% | 0.40% | Upgrade
|
| Earnings Yield | -52.07% | -26.41% | -23.74% | -24.68% | -27.99% | -12.43% | Upgrade
|
| FCF Yield | -34.88% | -26.22% | -35.71% | -33.30% | -35.50% | 5.33% | Upgrade
|
| Buyback Yield / Dilution | -16.43% | -9.40% | -16.69% | -16.73% | -206.64% | -24.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.